Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

BIOFLORIDA, INC.

Filed by BUCHANAN INGERSOLL & ROONEY PC.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 22, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
9afab6f0-9b67-452f-8e6e-7e461d2c71f0
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

CPT · Copyright/Patent/Trademark

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

HCR · Health Issues

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MAN · Manufacturing

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MED · Medical/Disease Research/Clinical Labs

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

MMM · Medicare/Medicaid

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

PHA · Pharmacy

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.